Mouse breast cancer EMT6 and 4T1 cells were treated with the high dose of IFN-γ (200 ng/mL), the diluent as a control, or the high dose of IFN-γ in the presence of an autophagy inhibitor for 3 days. This evidence concerns the gene IFNG and breast carcinoma.